Evaluation of the long-term cost-effectiveness of once-weekly semaglutide versus dulaglutide for treatment of type 2 diabetes mellitus in the UK

Date first appeared online	25/10/2018
DOI	10.1111/dom.13564
Authors	Bain S.
Journal Name	Diabetes, Obesity and Metabolism
Volume

Documents

• 48008.pdf , Book, Released under the terms of a Creative Commons Attribution-NonCommercial-NoDerivs License (CC-BY-NC-ND).